Lactate dehydrogenase A inhibition prevents RANKL-induced osteoclastogenesis by reducing enhanced glycolysis.

MLA

Nishioku, Tsuyoshi, et al. “Lactate Dehydrogenase A Inhibition Prevents RANKL-Induced Osteoclastogenesis by Reducing Enhanced Glycolysis.” Journal of Pharmacological Sciences, vol. 153, no. 4, Dec. 2023, pp. 197–207. EBSCOhost, https://doi.org/10.1016/j.jphs.2023.09.005.

APA

Nishioku, T., Anzai, R., Hiramatsu, S., Terazono, A., Nakao, M., & Moriyama, M. (2023). Lactate dehydrogenase A inhibition prevents RANKL-induced osteoclastogenesis by reducing enhanced glycolysis. Journal of Pharmacological Sciences, 153(4), 197–207. https://doi.org/10.1016/j.jphs.2023.09.005

Chicago

Nishioku, Tsuyoshi, Rumi Anzai, Sami Hiramatsu, Ayaka Terazono, Mamiko Nakao, and Miyu Moriyama. 2023. “Lactate Dehydrogenase A Inhibition Prevents RANKL-Induced Osteoclastogenesis by Reducing Enhanced Glycolysis.” Journal of Pharmacological Sciences 153 (4): 197–207. doi:10.1016/j.jphs.2023.09.005.